Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.

Fahmueller, Yvonne Nadine

Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients. [electronic resource] - International journal of cancer May 2013 - 2349-58 p. digital

Publication Type: Journal Article

1097-0215

10.1002/ijc.27894 doi


Adult
Aged
Alkaline Phosphatase--blood
Amylases--blood
Analysis of Variance
Antigens, Neoplasm--blood
Apoptosis--immunology
Biomarkers, Tumor--blood
C-Reactive Protein--metabolism
CA-19-9 Antigen--blood
Carcinoembryonic Antigen--blood
Catheter Ablation
Cholinesterases--blood
Colorectal Neoplasms--blood
Deoxyribonucleases--blood
Embolization, Therapeutic--methods
Female
HMGB1 Protein--blood
Humans
Kaplan-Meier Estimate
Keratin-19--blood
L-Lactate Dehydrogenase--blood
Lipase--blood
Liver Neoplasms--blood
Magnetic Resonance Imaging
Male
Middle Aged
Multimodal Imaging
Positron-Emission Tomography
Prognosis
Prospective Studies
Receptor for Advanced Glycation End Products
Receptors, Immunologic--blood
Tomography, X-Ray Computed
Treatment Outcome